Montelukast Prescribing at CONNER & PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
698
Total Quantity
20.0K
NHS Cost
£1.0K
vs National Avg
+1.9%
CONNER & PARTNERS prescribed 698 items of Montelukast over the last 12 months at a cost of £1,031 to the NHS. This is 1.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
56
Jun 2026
61
Jun 2026
64
Jun 2026
61
Jun 2026
64
Jun 2026
62
Jun 2026
53
Jun 2026
58
Jun 2026
61
Jun 2026
53
Jun 2026
60
Jun 2026
45
Prescribing Details
| Total Items | 698 |
|---|---|
| Total Quantity | 20,034 |
| Total NHS Cost | £1,031 |
| Presentations | 4 different forms |
| vs National Average | +1.9% |
Montelukast Prescribing Comparison
| This practice | 698 items |
|---|---|
| National average per practice | 685 items |
| Difference | +1.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.